A pilot trial of human amniotic fluid for the treatment of COVID-19

A pilot trial of human amniotic fluid for the treatment of COVID-19

Abstract Objective Vertical transmission from SARS CoV-2-infected women is uncommon and coronavirus has not been detected in amniotic fluid. Human amniotic products have a broad immune-mediating profile. Observing that many COVID-19 patients have a profound inflammatory response to the virus, we sou...

Full description

Bibliographic Details
Main Authors: Craig H. Selzman, Joseph E. Tonna, Jan Pierce, Camila Vargas, Chloe Skidmore, Giavonni Lewis, Nathan D. Hatton, John D. Phillips
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Research Notes
Subjects:
COVID-19
Amniotic fluid
Inflammation
C-reactive protein
Online Access:https://doi.org/10.1186/s13104-021-05443-9

Internet

https://doi.org/10.1186/s13104-021-05443-9

Similar Items